×
Entrez Id:
1401
Gene Symbol:
CRP
CRP
0.100
Biomarker
disease
BEFREE
Prognostic value of the C-reactive protein to albumin ratio in esophageal cancer : A systematic review and meta-analysis.
31512813
2020
×
Entrez Id:
1401
Gene Symbol:
CRP
CRP
0.100
AlteredExpression
disease
BEFREE
The present results suggest that the postoperative CRP level can be a prognosticator in patients with esophageal cancer who have received perioperative steroid therapy and ERAS care.
30804146
2019
×
Entrez Id:
1401
Gene Symbol:
CRP
CRP
0.100
AlteredExpression
disease
BEFREE
However, since elevated CRP levels are often observed in cStage III esophageal cancer , whether or not CRP still reflects the prognosis is unclear.
30167922
2019
×
Entrez Id:
1401
Gene Symbol:
CRP
CRP
0.100
Biomarker
disease
BEFREE
We investigated the relationship between postoperative CRP values according to the postoperative period and prognosis in esophageal cancer .
30396980
2018
×
Entrez Id:
1401
Gene Symbol:
CRP
CRP
0.100
AlteredExpression
disease
BEFREE
The present study aims to clarify the prognostic significance of postoperative CRP levels on the survival of patients with esophageal cancer .
28120093
2017
×
Entrez Id:
1401
Gene Symbol:
CRP
CRP
0.100
Biomarker
disease
BEFREE
CRP value on POD 4 may be useful for predicting SICs in esophageal cancer patients who receive radical esophagectomy with perioperative steroid therapy and ERAS care.
29202716
2017
×
Entrez Id:
1401
Gene Symbol:
CRP
CRP
0.100
AlteredExpression
disease
BEFREE
A CRP genetic polymorphism associated with the tumoral expression of CRP in esophageal cancer .
22911253
2013
×
Entrez Id:
1401
Gene Symbol:
CRP
CRP
0.100
GeneticVariation
disease
BEFREE
Promising markers that emerged for the prediction of overall survival in esophageal squamous cell cancer included VEGF (18 eligible studies, n=1476, HR=1.85, 95% CI, 1.55-2.21), cyclin D1 (12 eligible studies, n=1476, HR=1.82, 95% CI, 1.50-2.20), Ki-67 (3 eligible studies, n=308, HR=1.11, 95% CI, 0.70-1.78) and squamous cell carcinoma antigen (5 eligible studies, n=700, HR=1.28, 95% CI, 0.97-1.69); prognostic markers for esophageal adenocarcinoma included COX-2 (2 eligible studies, n=235, HR=3.06, 95% CI, 2.01-4.65) and HER-2 (3 eligible studies, n=291, HR=2.15, 95% CI, 1.39-3.33); prognostic markers for uncategorized EC s included p21 (9 eligible studies, n=858, HR=1.27, 95% CI, 0.75-2.16), p53 (31 eligible studies, n=2851, HR=1.34, 95% CI, 1.21-1.48), CRP (8 eligible studies, n=1382, HR=2.65, 95% CI, 1.64-4.27) and hemoglobin (5 eligible studies, n=544, HR=0.91, 95% CI, 0.83-1.00).
24206575
2013
×
Entrez Id:
1401
Gene Symbol:
CRP
CRP
0.100
GeneticVariation
disease
BEFREE
In addition, we previously showed that the CRP 1846T/T genotype is related to lymph node metastasis in patients with esophageal cancer .
20686879
2010
×
Entrez Id:
1401
Gene Symbol:
CRP
CRP
0.100
AlteredExpression
disease
BEFREE
The purpose of this study was to assess the association between CRP polymorphisms and acute-phase serum CRP levels after esophagectomy for thoracic esophageal cancer .
19801321
2009
×
Entrez Id:
1401
Gene Symbol:
CRP
CRP
0.100
Biomarker
disease
BEFREE
Two hundred and three newly diagnosed patients with gastric or oesophageal cancer had serum CRP and cytokine concentrations determined by ELISA.
17103073
2007